Unexplained Infertility: What the Diagnosis Means and What Usually Comes Next
Key Takeaways
Unexplained infertility means the standard evaluation has not identified a clear cause. It does not mean conception is impossible or that an unproven hidden disorder has been found. Age, duration of infertility, previous pregnancy and treatment history, and personal priorities help determine whether expectant management, ovarian stimulation with IUI, or IVF is the next step.
Key evidence: ASRM — Evidence-based treatments for unexplained infertility (2020) ASRM — Fertility evaluation of infertile women (2021) ESHRE — Unexplained infertility guideline (2023)
Unexplained Infertility: What the Diagnosis Means — Dr. Senai Aksoy
Hearing the phrase “unexplained infertility” can be disorienting. You complete every test, wait for answers, and are told everything looks normal. Month after month, though, pregnancy still has not happened.
“Unexplained” does not mean your struggle is imaginary, and it does not mean there is no biological reason at all. It means that routine testing has reached its diagnostic limits (ESHRE, 2023).
Up to 30% of couples undergoing a standard infertility evaluation receive this classification (ASRM, 2020). It is not a dead end. It is a starting point for choosing the next step without pretending that the missing mechanism has been identified.
What the Diagnosis Actually Means
The diagnosis is made by exclusion. Standard tests have not found an ovulatory, tubal, uterine, or semen factor that clearly explains why pregnancy has not occurred.
A standard evaluation usually includes:
- A menstrual history consistent with regular ovulation
- At least one patent fallopian tube, usually assessed with hysterosalpingography (HSG) or hysterosalpingo-contrast sonography (HyCoSy)
- Ultrasound assessment of the uterus and uterine cavity
- A semen analysis without a clear male-factor explanation
The ASRM fertility-evaluation opinion and the ESHRE guideline describe unexplained infertility as a diagnosis of exclusion. No single positive test confirms it. The exact work-up should still reflect symptoms and medical history.
If the original work-up was incomplete or is now out of date, the first step may be to finish or revisit it. New pelvic pain, irregular cycles, abnormal bleeding, a changed semen analysis, or a long delay since tubal assessment can raise a specific question that deserves review.
What Routine Tests Can Miss
Standard fertility tests assess the factors that can be measured reliably in routine care. They cannot observe every step between ovulation and implantation, but that gap should not be mistaken for proof of a specific hidden disorder.
- Sperm function: A semen analysis measures concentration, movement, and shape. It cannot capture every step in sperm function. Even so, ESHRE does not recommend routine sperm DNA-fragmentation testing when semen results are normal.
- Mild endometriosis: Small lesions may not appear on ultrasound. Their effect varies. Possible mild disease alone does not justify routine laparoscopy without symptoms or another reason for surgery.
- Fertilisation and embryo development: These events cannot be observed during unassisted conception. IVF shows what happens in the laboratory. It cannot prove why pregnancy did not occur naturally.
- Endometrial biology: A normal ultrasound cannot measure every event involved in implantation. This limit does not diagnose a displaced implantation window. It also does not establish a need for receptivity testing.
For this reason, a long list of advanced tests is not automatically useful. The ESHRE guideline notes that evidence for many additional tests is limited. Further testing should answer a question raised by symptoms, history, or previous treatment rather than simply fill the uncertainty.
The unexplained infertility label does not establish an immune disorder either. ESHRE does not recommend routine thyroid-antibody or other autoimmune testing. Coeliac disease assessment may be considered in selected women. Anti-sperm antibody testing is also not part of the routine work-up (ESHRE, 2023). Unproven immune tests or treatments should not replace standard care. For details, see immunological treatments and IVF implantation.
When Expectant Management Is Reasonable
Expectant management can be reasonable when the chance of conception without treatment remains favourable. There should also be no reason to shorten the timeline.
The most useful factors are female age, duration of infertility, previous pregnancy, and previous treatment. ESHRE notes that ovarian reserve testing can help predict response to stimulation. It does not reliably predict natural conception over the next 6 to 12 months.
Younger age and a shorter duration of infertility generally point towards a better prognosis. Prediction models still have limits and have not been validated in every population. The ESHRE guideline therefore recommends using the overall prognosis and patient preferences. A single age, AMH result, or duration cut-off should not decide when treatment starts.
Guidelines do not use one universal clock. The 2026 NICE guideline for the UK advises trying for a total of two years before treatment in this setting, while ESHRE emphasises an individualised prognosis. Neither guideline sets a personal timetable.
Expectant management should have an agreed review date. If pregnancy has not occurred by then, the prognosis and treatment options can be reassessed without allowing an open-ended wait.
Stepwise Treatment Pathways: IUI and IVF
When active treatment is chosen, ovarian stimulation with intrauterine insemination (IUI) is often the first step. IVF may follow unsuccessful IUI or be considered earlier when age, previous treatment, or the couple’s timeline changes the balance.
1. Ovarian Stimulation with Intrauterine Insemination (IUI)
A common first step is 3 to 4 cycles of stimulation with an oral medicine and IUI. The medicine is usually clomiphene citrate or letrozole (ASRM, 2020). Gonadotropin-IUI is not a routine substitute. It is more complex and can raise the risk of multiple pregnancy without a clear live-birth benefit over oral medicines.
Protocols still differ between guidelines and clinics. In its UK pathway, NICE NG257 allows discussion of up to four gonadotropin-stimulated IUI cycles after two years of trying, or IVF instead. The appropriate regimen depends on the clinical setting and the couple’s risk profile; it should not be copied from a general article.
The medication aims to recruit a limited number of follicles, while insemination places prepared sperm in the uterus near ovulation. As the number of developing follicles rises, so do the risks of multiple pregnancy and, less commonly, ovarian hyperstimulation syndrome. Monitoring, conservative dosing, and clear cycle-cancellation rules are therefore part of treatment, not optional extras (ASRM, 2020).
2. In Vitro Fertilisation (IVF)
IVF generally offers a higher chance of live birth per treatment cycle than oral-agent IUI. It is more invasive, and its benefit depends strongly on age and prior treatment. IVF also shows events that cannot be seen during unassisted conception. These observations are useful, but they do not make IVF a definitive diagnostic test.
- Conventional IVF shows whether fertilisation occurs in the laboratory. ICSI bypasses sperm penetration, so the two methods do not provide the same information
- Embryo culture records development and appearance. Appearance alone does not prove genetic health or implantation potential
- IVF bypasses fallopian-tube transport and allows embryo-transfer strategy to be planned
For women aged 38 or older, ASRM reports that immediate IVF may shorten time to pregnancy. It may also improve pregnancy rates compared with beginning with IUI. For younger women, IVF is commonly considered after 3 to 4 unsuccessful oral-agent IUI cycles. Reduced ovarian reserve, a longer duration of infertility, or a wish for a shorter route with a higher chance per attempt can also bring the discussion forward. Previous pregnancy, treatment history, cost, burden, and personal priorities still matter at every age (ASRM, 2020).
For couples planning care away from home, our IVF in Turkey guide explains the records, timing, and coordination involved in international treatment.
Dr. Aksoy’s Approach
Dr. Aksoy gives the greatest weight to female age and the risk of losing time. He becomes more inclined to recommend IVF after age 35, particularly at 38 or older. Infertility lasting more than two years or failure after 3 to 4 well-planned stimulated IUI cycles also shifts the balance towards IVF.
For younger couples who have been trying for a shorter time, have patent tubes, and have a normal semen analysis, 3 to 4 stimulated IUI cycles can still be a reasonable first step. A significant male factor, tubal problem, or suspicion of endometriosis changes that pathway and may call for earlier IVF or further targeted evaluation.
AMH does not, by itself, mean that IVF is mandatory or that natural conception is impossible. It mainly helps estimate the likely ovarian response to stimulation. When AMH is very low and age is also advancing, however, avoiding months of potentially low-yield treatment becomes more important. In that setting, Dr. Aksoy is more likely to discuss moving to IVF earlier.
The Selective Role of Surgery
Diagnostic surgery is not routinely required for unexplained infertility. It becomes relevant when symptoms, history, or imaging point to a specific condition that could change management.
Routine diagnostic laparoscopy is not recommended before treatment (ESHRE, 2023). It may be considered when there is chronic pelvic pain or severe dysmenorrhoea. Abnormal imaging or a relevant medical history may also raise suspicion of endometriosis, adhesions, or another pelvic disorder.
Hysteroscopy should not be added routinely after normal uterine imaging simply to search for an unseen abnormality. It can be appropriate when imaging is abnormal or another specific indication is present. Our guide to diagnostic hysteroscopy before IVF explains that distinction.
How to Prepare for the Treatment Decision
Bring the original reports rather than only a summary of “normal tests.” A useful review includes:
- cycle and ovulation records
- tubal and uterine-cavity imaging reports
- all semen analyses, with dates
- ovarian reserve results and the context in which they were measured
- previous stimulation or IUI protocols and follicle response
- pregnancy, miscarriage, surgery, infection, and endometriosis history
Ask what would make the plan change. A clear consultation should define why the proposed step fits now, how many attempts are reasonable, what safety limits apply, and when the plan will be reviewed.
The Emotional Side of an Unexplained Diagnosis
An “unexplained” diagnosis is often harder to carry than a named condition. When every result comes back “normal” and pregnancy still does not happen, frustration is a natural response.
It can help to turn that uncertainty into a plan with clear time horizons and fixed review dates.
Frequently Asked Questions for Dr. Aksoy
Can a couple with unexplained infertility still conceive naturally, even after stopping treatment?
Yes. Some couples with this diagnosis conceive without any treatment. Unexplained infertility does not mean that pregnancy is impossible. It means our tests found no clear problem with ovulation, the tubes or the sperm, but we cannot yet explain why pregnancy has not happened. The chance of a natural pregnancy is not zero, although it is usually lower than in couples with normal fertility.
A spontaneous pregnancy can also happen after treatment stops. I see it even in couples who have had unsuccessful IVF attempts. It would be wrong, however, to read it as a delayed effect of stopping treatment, of less stress or of the medicines used.
The three facts that matter most to me are the woman’s age, how long the couple has been trying and whether there has been a previous pregnancy. I would not assess a 28-year-old who has been trying for a year with entirely normal tests in the same way as a 39-year-old who has not conceived in four years. For the first couple, waiting a while longer for a natural pregnancy can be reasonable. For the second, not losing time becomes more important. Natural pregnancy remains possible, but how long each couple can wait has to be decided case by case.
Do lifestyle changes help when the cause is unexplained?
I recommend healthy habits to every couple, but they should not be seen as a treatment that removes unexplained infertility. Stopping smoking, avoiding heavy drinking, staying active and keeping a healthy weight matter for both partners. We know that smoking harms fertility, and being clearly overweight or underweight can also affect reproductive health.
We do not, however, have strong evidence that a couple with unexplained infertility will conceive simply by losing weight, changing their diet or starting regular exercise. The same applies to vitamins, antioxidants and supplements marketed for fertility. A deficiency should be corrected, but taking many supplements without one has not been shown to increase the chance of a live birth.
I often tell my patients that you can do everything right and still not conceive, and that this does not mean you did something wrong. Lifestyle changes can support general health and preparation for pregnancy. Postponing treatment for years while making them may not be the right approach, especially as the woman gets older. The aim is healthy habits, not placing the whole responsibility for unexplained infertility on the couple’s lifestyle.
When should we move from IUI to IVF?
Female age and the risk of losing time weigh most in my decision. After 35 I become more inclined to recommend IVF, and at 38 or older I generally prefer it to spending months on three or four stimulated IUI cycles. Reduced ovarian reserve, infertility lasting more than two years, or a plan for more than one child push me in the same direction. In a younger woman with reassuring ovarian reserve, a shorter duration of infertility, patent tubes, a normal semen analysis and no previous treatment, three or four IUI cycles with an oral medicine can be a reasonable first step. If several well-conducted IUI cycles have already failed, raising the gonadotropin dose adds multiple-pregnancy risk while the time and cost advantage shrinks. The question I then ask is whether the couple can still afford a few more months on a lower-probability option. A significant male factor, a tubal problem or suspected endometriosis changes this pathway from the start.
How well does IVF work when the cause is unexplained?
Unexplained infertility is one of the situations in which IVF can be effective, but I do not recommend it straight away to every couple whose cause we cannot find. In IVF we collect the eggs, fertilise them with sperm in the laboratory and follow the embryos as they develop. This lets us assess fertilisation and early embryo development, steps we cannot observe in a natural pregnancy. Sometimes we see a problem at these stages. Even when everything goes normally in the laboratory, we may still be unable to say for certain why pregnancy did not happen before.
The woman’s age is one of the most important factors in the outcome. Ovarian reserve, the duration of infertility, previous pregnancies and earlier treatments also shape my advice. For a young couple who have been trying for a short time and still have a good chance of natural conception, I may prefer waiting a little longer or ovarian stimulation with IUI. If the woman is 38 to 40, infertility has lasted a long time, or several IUI attempts have failed, I consider moving to IVF earlier.
ICSI is not always needed in unexplained infertility. If there is no clear sperm problem, conventional IVF can be appropriate; we have no evidence that ICSI gives a higher live-birth rate for every patient. IVF is an effective option here, but its success rate cannot be stated from this diagnosis alone. When to start and what to expect depend on the couple’s age, history and previous results.
Summary
An unexplained infertility diagnosis describes the limits of routine testing. It does not determine your prognosis. Age, duration of infertility, previous pregnancy and treatment, and personal priorities provide a more useful framework. Together with your specialist, you can use these factors to choose between a defined period of expectant management, stimulated IUI, or IVF.
Sources
- American Society for Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: a guideline. Fertil Steril. 2020;113(2):305-322.
- Practice Committee of the American Society for Reproductive Medicine. Fertility evaluation of infertile women: a committee opinion. Fertil Steril. 2021;116(5):1255-1265.
- ESHRE Guideline Group on Unexplained Infertility. Evidence-based guideline: unexplained infertility. Hum Reprod. 2023;38(10):1881-1890. doi:10.1093/humrep/dead150.
- National Institute for Health and Care Excellence. Fertility problems: assessment and treatment — unexplained fertility problems. NICE guideline NG257. 2026.
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.